Navigation path

Calls for proposals

The 3rd Call FP7 is closed

The 4th Call FP7 is closed


Health workprogramme 2011 (publication medio 2010) : the area of NID is closed

Health workprogramme 2012 (expected publication medio 2012) : the area of NID
is expected to be open.

Subscribe to our mailing list to receive up-to-date information.

2.3.4. Neglected infectious diseases

The aim of this area is to establish an integrated approach for the development of preventive, therapeutic and diagnostic, tools for neglected infectious diseases. Activities will address, but not be limited to, parasitic diseases caused by Trypanosomatidae species (Trypanosomiasis, Chagas Disease, Leishmaniasis), bacterial diseases such as Buruli ulcer, leprosy and trachoma, helminth diseases such as schistosomiasis, as well as health conditions that can be caused by several pathogens, such as childhood diarrhoea. Projects should address preclinical and early clinical activities, as well as the particular public health conditions and health needs of disease endemic countries. Proposals involving an integrated multidisciplinary approach, including significant participation of partners from disease-endemic areas and, where relevant, industry partners could lead to an increased impact of the research proposed, and this will be considered in the evaluation of the proposal. Where applicable, technology transfer, training activities and human capacity building should also be part of the projects.

Note: For topics under this area applicants will have to follow the rules for single-stage submission procedure (see respective call fiche in section III).


HEALTH.2010.2.3.4-1: Vaccines for childhood bacterial diarrhoeal diseases. FP7- HEALTH-2010-single-stage.

Research should be focused on accelerating the development of vaccine candidates to clinical testing. Testing in vitro and in vivo should form part of the project, which may also include early clinical trials. Priority will be given to projects on multivalent vaccines that aim to work across different strains of either Enterotoxigenic Escherichia coli (ETEC) or Shigella. Vaccines should be suitable for use in endemic regions, and involvement of partners from International Cooperation Partner Countries (ICPC) countries as well as partners with expertise in industrial vaccine production could lead to an increased impact of the research proposed and this will be considered in the evaluation of the proposal. Active participation of SMEs could lead to an increased impact of the proposed research and this will be considered in the evaluation of the proposal.

Note: Limits on the EC financial contribution apply. These are implemented strictly as formal eligibility criteria. You must refer to the call fiche for details of these limits.
Funding scheme: Specific International Cooperation Action (SICA) Collaborative Project (Large scale integrating project) Target Region: all ICPC
EC contribution per project: min. EUR 6 000 000 – max. EUR 12 000 000
Only up to one proposal can be selected.
Expected impact: Research shall gather a multi-disciplinary team of vaccinologists from Europe, disease-endemic countries and elsewhere and establish a comprehensive pipeline of candidate vaccines against one of the major enteric bacterial pathogens causing childhood diarrhoea. The consortium shall have the capacity to undertake the full pre-clinical development of vaccine candidates, safety and toxicology studies, and have the ambition to advance the most promising candidate(s) into early clinical testing (phase I/IIa).


HEALTH.2010.2.3.4-2: Comprehensive control of Neglected Infectious Diseases (NID). FP7-HEALTH-2010-single-stage.

Research should aim at developing an improved system for delivering primary health care in resource poor settings. This project should aim to overcome the vertical approach of many disease-specific control programmes, and develop methods that are more adapted to a primary health care setting. The proposed research should address several of the NID priority diseases, while not necessarily be limited to these. The project should aim at integrating existing prevention methods with new diagnostic methodology and diagnosis-treatment algorithms adapted to resource-poor settings. The project can include the development of new or optimized diagnostic platform for multiple infectious diseases, but the proposed prevention and treatment options should be based on existing and affordable tools, vaccines and medication. Innovative research on intervention delivery may be included. Finally, the project should also aim to develop primary health care recommendations for use by policy makers and health care managers in disease endemic countries. Active participation of SMEs could lead to an increased impact of the research proposed and this will be considered in the evaluation of the proposal.

Note: Limits on the EC financial contribution apply. These are implemented strictly as formal eligibility criteria. You must refer to the call fiche for details of these limits.
Funding scheme: Specific International Cooperation Action (SICA) Collaborative Project (Small- or medium scale focused research project) Target Region: all International Cooperation Partner Countries (ICPC)
EC contribution per project: max. EUR 6 000 000
One or more proposals can be selected.
Expected impact: Research must bridge vertical, disease-specific approaches and must use state-of-the-art epidemiological and diagnostic knowledge and technology to develop 1) a single comprehensive, low-cost diagnostic system that is suitable for use in resource poor settings and 2) diagnosis-treatment algorithms on the basis of existing prophylactics and medication, and 3) document the cost-savings and increased efficacy of a comprehensive, horizontal approach to NID, and develop recommendations for broad implementation to policy makers, relevant international organisations, and health care managers.


HEALTH.2010.2.3.4-3: Next generation of researchers for Neglected Infectious Diseases. FP7-HEALTH-2010-single-stage.

Coordination is requested for targeted measures aiming at improving the career prospects for young researches in neglected infectious diseases. The activities should comprise training of young scientists, and support young researchers to establish independent research activities in disease-endemic countries. High quality science contents, demonstrated organisation and management abilities and clear indications of sustainability and impact will be prerequisites of selected actions. Coordination with ongoing EC activities to support training of researchers in poverty-related diseases (PRD) is encouraged.

Note: Limits on the EC financial contribution apply. These are implemented strictly as formal eligibility criteria. You must refer to the call fiche for details of these limits.
Funding scheme: Coordination and Support Action (Coordinating action)
EC contribution per project: max. EUR 2 000 000
One or more proposals can be selected.
Expected impact: The Coordination Action is expected to establish a long-term training programme that is open to promising young scientists in neglected infectious diseases. It should further manage a career development programme to support young researchers in establishing themselves with independent research in disease-endemic countries. The action should establish collaboration with ongoing training and career development activities in poverty-related diseases with an aim to establish a joint, coordinated programme.

For more information